Primary Site >> Stomach Cancer

Gene >> NRAS

  • 1990
  • 1997
  • 2011
  • 2013
  • 2014
  • 2015
  • 2017
Ref: No evidence for point mutations in codons 12, 13, and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers.
PMID: 2199031
 Ref: Rare occurrence of ras and p53 gene mutations in mouse stomach tumors induced by N-methyl-N-nitrosourea.
PMID: 9197527
Ref: [Detection of ras gene mutation in various stages of gastric cancer by PCR/RFLP SSCP and DNA sequencing].
PMID: 10436968
 Ref: Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer.
PMID: 21676433
 Ref: Prognostic and putative predictive biomarkers of gastric cancer for personalized medicine.
PMID: 23846438
 Ref: Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer.
PMID: 24774510
 Ref: MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2.
PMID: 26458859
Ref: Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer.
PMID: 26567773
 Ref: Molecular Testing for Gastrointestinal Cancer.
PMID: 28219002
Ref: Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.
PMID: 29307989